Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia

Richard P. Sullivan, Jane Davies, Paula Binks, Roslyn Gundjirryiir Dhurrkay, George Garambaka Gurruwiwi, Sarah Mariyalawuy Bukulatjpi, Melita McKinnon, Kelly Hosking, Margaret Littlejohn, Kathy Jackson, Stephen Locarnini, Joshua S. Davis, Steven Y.C. Tong

Research output: Contribution to journalArticle

Abstract

Many Indigenous Australians in northern Australia living with chronic hepatitis B are unaware of their diagnosis due to low screening rates. A venous blood point of care test (POCT) or oral fluid laboratory test could improve testing uptake in this region. The purpose of this study was to assess the field performance of venous blood POCT and laboratory performance of an oral fluid hepatitis B surface antigen (HBsAg) test in Indigenous individuals living in remote northern Australian communities. The study was conducted with four very remote communities in the tropical north of Australia's Northern Territory. Community research workers collected venous blood and oral fluid samples. We performed the venous blood POCT for HBsAg in the field. We assessed the venous blood and oral fluid specimens for the presence of HBsAg using standard laboratory assays. We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the POCT and oral fluid test, using serum laboratory detection of HBsAg as the gold standard. From 215 enrolled participants, 155 POCT and 197 oral fluid tests had corresponding serum HBsAg results. The POCT had a sensitivity of 91.7% and specificity of 100%. Based on a population prevalence of 6%, the PPV was 100% and NPV was 99.5%. The oral fluid test had a sensitivity of 56.8%, specificity of 98.1%, PPV of 97.3% and NPV of 65.9%. The venous blood POCT has excellent test characteristics and could be used to identify individuals with chronic HBV infection in high prevalence communities with limited access to health care. Oral fluid performance was suboptimal.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal of Viral Hepatitis
DOIs
Publication statusE-pub ahead of print - 29 Nov 2019

Fingerprint

Point-of-Care Systems
Hepatitis B
Hepatitis B Surface Antigens
Sensitivity and Specificity
Northern Territory
Health Services Accessibility
Chronic Hepatitis B
Serum

Cite this

Sullivan, Richard P. ; Davies, Jane ; Binks, Paula ; Dhurrkay, Roslyn Gundjirryiir ; Gurruwiwi, George Garambaka ; Bukulatjpi, Sarah Mariyalawuy ; McKinnon, Melita ; Hosking, Kelly ; Littlejohn, Margaret ; Jackson, Kathy ; Locarnini, Stephen ; Davis, Joshua S. ; Tong, Steven Y.C. / Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia. In: Journal of Viral Hepatitis. 2019 ; pp. 1-8.
@article{353b3150c5d341579ebca2ed3b8cef91,
title = "Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia",
abstract = "Many Indigenous Australians in northern Australia living with chronic hepatitis B are unaware of their diagnosis due to low screening rates. A venous blood point of care test (POCT) or oral fluid laboratory test could improve testing uptake in this region. The purpose of this study was to assess the field performance of venous blood POCT and laboratory performance of an oral fluid hepatitis B surface antigen (HBsAg) test in Indigenous individuals living in remote northern Australian communities. The study was conducted with four very remote communities in the tropical north of Australia's Northern Territory. Community research workers collected venous blood and oral fluid samples. We performed the venous blood POCT for HBsAg in the field. We assessed the venous blood and oral fluid specimens for the presence of HBsAg using standard laboratory assays. We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the POCT and oral fluid test, using serum laboratory detection of HBsAg as the gold standard. From 215 enrolled participants, 155 POCT and 197 oral fluid tests had corresponding serum HBsAg results. The POCT had a sensitivity of 91.7{\%} and specificity of 100{\%}. Based on a population prevalence of 6{\%}, the PPV was 100{\%} and NPV was 99.5{\%}. The oral fluid test had a sensitivity of 56.8{\%}, specificity of 98.1{\%}, PPV of 97.3{\%} and NPV of 65.9{\%}. The venous blood POCT has excellent test characteristics and could be used to identify individuals with chronic HBV infection in high prevalence communities with limited access to health care. Oral fluid performance was suboptimal.",
keywords = "diagnosis, hepatitis B, point of care testing, serologic tests",
author = "Sullivan, {Richard P.} and Jane Davies and Paula Binks and Dhurrkay, {Roslyn Gundjirryiir} and Gurruwiwi, {George Garambaka} and Bukulatjpi, {Sarah Mariyalawuy} and Melita McKinnon and Kelly Hosking and Margaret Littlejohn and Kathy Jackson and Stephen Locarnini and Davis, {Joshua S.} and Tong, {Steven Y.C.}",
year = "2019",
month = "11",
day = "29",
doi = "10.1111/jvh.13243",
language = "English",
pages = "1--8",
journal = "Journal of Viral Hepatitis",
issn = "1345-2533",
publisher = "Wiley-Blackwell",

}

Sullivan, RP, Davies, J, Binks, P, Dhurrkay, RG, Gurruwiwi, GG, Bukulatjpi, SM, McKinnon, M, Hosking, K, Littlejohn, M, Jackson, K, Locarnini, S, Davis, JS & Tong, SYC 2019, 'Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia', Journal of Viral Hepatitis, pp. 1-8. https://doi.org/10.1111/jvh.13243

Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia. / Sullivan, Richard P.; Davies, Jane; Binks, Paula; Dhurrkay, Roslyn Gundjirryiir; Gurruwiwi, George Garambaka; Bukulatjpi, Sarah Mariyalawuy; McKinnon, Melita; Hosking, Kelly; Littlejohn, Margaret; Jackson, Kathy; Locarnini, Stephen; Davis, Joshua S.; Tong, Steven Y.C.

In: Journal of Viral Hepatitis, 29.11.2019, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia

AU - Sullivan, Richard P.

AU - Davies, Jane

AU - Binks, Paula

AU - Dhurrkay, Roslyn Gundjirryiir

AU - Gurruwiwi, George Garambaka

AU - Bukulatjpi, Sarah Mariyalawuy

AU - McKinnon, Melita

AU - Hosking, Kelly

AU - Littlejohn, Margaret

AU - Jackson, Kathy

AU - Locarnini, Stephen

AU - Davis, Joshua S.

AU - Tong, Steven Y.C.

PY - 2019/11/29

Y1 - 2019/11/29

N2 - Many Indigenous Australians in northern Australia living with chronic hepatitis B are unaware of their diagnosis due to low screening rates. A venous blood point of care test (POCT) or oral fluid laboratory test could improve testing uptake in this region. The purpose of this study was to assess the field performance of venous blood POCT and laboratory performance of an oral fluid hepatitis B surface antigen (HBsAg) test in Indigenous individuals living in remote northern Australian communities. The study was conducted with four very remote communities in the tropical north of Australia's Northern Territory. Community research workers collected venous blood and oral fluid samples. We performed the venous blood POCT for HBsAg in the field. We assessed the venous blood and oral fluid specimens for the presence of HBsAg using standard laboratory assays. We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the POCT and oral fluid test, using serum laboratory detection of HBsAg as the gold standard. From 215 enrolled participants, 155 POCT and 197 oral fluid tests had corresponding serum HBsAg results. The POCT had a sensitivity of 91.7% and specificity of 100%. Based on a population prevalence of 6%, the PPV was 100% and NPV was 99.5%. The oral fluid test had a sensitivity of 56.8%, specificity of 98.1%, PPV of 97.3% and NPV of 65.9%. The venous blood POCT has excellent test characteristics and could be used to identify individuals with chronic HBV infection in high prevalence communities with limited access to health care. Oral fluid performance was suboptimal.

AB - Many Indigenous Australians in northern Australia living with chronic hepatitis B are unaware of their diagnosis due to low screening rates. A venous blood point of care test (POCT) or oral fluid laboratory test could improve testing uptake in this region. The purpose of this study was to assess the field performance of venous blood POCT and laboratory performance of an oral fluid hepatitis B surface antigen (HBsAg) test in Indigenous individuals living in remote northern Australian communities. The study was conducted with four very remote communities in the tropical north of Australia's Northern Territory. Community research workers collected venous blood and oral fluid samples. We performed the venous blood POCT for HBsAg in the field. We assessed the venous blood and oral fluid specimens for the presence of HBsAg using standard laboratory assays. We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the POCT and oral fluid test, using serum laboratory detection of HBsAg as the gold standard. From 215 enrolled participants, 155 POCT and 197 oral fluid tests had corresponding serum HBsAg results. The POCT had a sensitivity of 91.7% and specificity of 100%. Based on a population prevalence of 6%, the PPV was 100% and NPV was 99.5%. The oral fluid test had a sensitivity of 56.8%, specificity of 98.1%, PPV of 97.3% and NPV of 65.9%. The venous blood POCT has excellent test characteristics and could be used to identify individuals with chronic HBV infection in high prevalence communities with limited access to health care. Oral fluid performance was suboptimal.

KW - diagnosis

KW - hepatitis B

KW - point of care testing

KW - serologic tests

UR - http://www.scopus.com/inward/record.url?scp=85076907886&partnerID=8YFLogxK

U2 - 10.1111/jvh.13243

DO - 10.1111/jvh.13243

M3 - Article

C2 - 31785060

AN - SCOPUS:85076907886

SP - 1

EP - 8

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1345-2533

ER -